Tato stránka byla automaticky přeložena a přesnost překladu není zaručena. Podívejte se prosím na anglická verze pro zdrojový text.

Chronic Obstructive Pulmonary Disease Patient Preferences Survey

1. prosince 2020 aktualizováno: Dennis Jensen, Ph.D., McGill University

COPD Patient Preferences, Activities, and Participation Survey

The purpose of this study is to distribute a questionnaire created for individuals living with chronic obstructive pulmonary disease (COPD) to assess their activities, participation, and healthcare and COPD-related research priorities. The data collected will be compared across diagnosed COPD stages and disease severity to determine the extent to which adults with COPD participate in the listed activities and identify their primary research and healthcare related priorities. The questionnaire was originally developed based on past research then verified by a panel of COPD and participation experts; as well as, individuals living with COPD in the form of focus groups. The questionnaire will now be administered to 200 individuals living COPD (50 in each GOLD stage) at three sites across Montreal where clinical data for each participant will be available. This phase will help establish the reliability of the questionnaire.

Přehled studie

Postavení

Dokončeno

Intervence / Léčba

Typ studie

Pozorovací

Zápis (Aktuální)

200

Kontakty a umístění

Tato část poskytuje kontaktní údaje pro ty, kteří studii provádějí, a informace o tom, kde se tato studie provádí.

Studijní místa

    • Quebec
      • Montreal, Quebec, Kanada, H4A 3J1
        • Montreal Chest Institute of the McGill University Health Center (MUHC)

Kritéria účasti

Výzkumníci hledají lidi, kteří odpovídají určitému popisu, kterému se říká kritéria způsobilosti. Některé příklady těchto kritérií jsou celkový zdravotní stav osoby nebo předchozí léčba.

Kritéria způsobilosti

Věk způsobilý ke studiu

40 let až 90 let (Dospělý, Starší dospělý)

Přijímá zdravé dobrovolníky

Ne

Pohlaví způsobilá ke studiu

Všechno

Metoda odběru vzorků

Vzorek nepravděpodobnosti

Studijní populace

Adults living with chronic obstructive pulmonary disease (COPD).

Popis

Inclusion Criteria:

  • Clinical diagnosis of COPD
  • English or French speaking
  • Patient at one of the three participating sites with medical chart

Exclusion Criteria:

  • No diagnosis of COPD by a healthcare professional
  • Unable to communicate in English or French
  • Unable to provide informed consent
  • No medical chart information at one of the three participating sites

Studijní plán

Tato část poskytuje podrobnosti o studijním plánu, včetně toho, jak je studie navržena a co studie měří.

Jak je studie koncipována?

Detaily designu

Kohorty a intervence

Skupina / kohorta
Intervence / Léčba
Quartile 1 [Mild]
Participants will answer an online survey and their medical chart information will be gathered to compare responses across disease severity.
Quartile 2 [Moderate]
Participants will answer an online survey and their medical chart information will be gathered to compare responses across disease severity.
Quartile 3 [Severe]
Participants will answer an online survey and their medical chart information will be gathered to compare responses across disease severity.
Quartile 4 [Very Severe]
Participants will answer an online survey and their medical chart information will be gathered to compare responses across disease severity.

Co je měření studie?

Primární výstupní opatření

Měření výsledku
Popis opatření
Časové okno
Number of Participants Who Prioritized Healthcare Topics
Časové okno: Baseline
Twenty-four healthcare topics were selected once again from a literature and expert panel review, as well as corroborated by individuals living with COPD in five focus groups. Example healthcare topics include: relief of breathlessness; increase maximal amount of exercise individuals living with COPD can do inside and outside their homes; and prevent-lung flare-ups. Participants were asked to indicate their preference of the topics by assigning a percentage of their time, in increments of 10%, to the various healthcare topics, for a total of 100% of their time. For the 24 healthcare topics, individuals could select up to 10 topics (10% times 10 topics, for 100% of their time). The top five topics are presented as the most important topics for the participants and are indicative of areas of focus for future healthcare and research. The top five were presented in accordance to the request from the working group who developed the survey and reviewed the results.
Baseline
Number of Participants Who Prioritized Research Topics
Časové okno: Baseline
Individuals were asked to indicate their research priorities from a list of research topics using a modified willingness-to-pay method (Kawata et al., 2014). The willingness-to-pay method allows individuals to assign preference to various topics by assigning a percentage of funds to the topic. A list of 22 research topics (e.g., to relieve breathlessness in individuals living with COPD, to increase access to lung transplantations) was created for this study through a literature review, expert consultation, and five focus groups with individuals living with COPD (n=23, 27% women). Individuals were asked to assign a percentage of funds, in increments of 10% of funding, to the 22 COPD research topics. Participants could assign anywhere between 10% of funding to 100% of funding to the topics. The top five were presented in accordance to the request from the working group who developed the survey and reviewed the results.
Baseline
Number of Participants Who Were Not Satisfied With Their Participation in Daily and Social Activities
Časové okno: Baseline

Participants will answer questions about their participation in 26 daily activities, as well as their desire to participate in each of the 26 daily activities. This is a measure of those who indicated they wanted to increase their participation. 10 of the 26 activities and their outcome measures are listed below.

Activity 1: Walking from one place to another outside of your home on a flat surface.

Activity 2: Moving from one place to another using motorized transportation.

Activity 3: Climbing two or more flights of stairs.

Activity 4: Walking up a hill.

Activity 5: Participating in regular exercise.

Activity 6: Walking from one place to another in your home.

Activity 7: Carrying light objects on a flat surface.

Activity 8: Carrying heavy objects on a flat surface.

Activity 9: Carrying-out low intensity physical activities

Baseline

Sekundární výstupní opatření

Měření výsledku
Popis opatření
Časové okno
Forced Expiratory Volume in 1-sec (FEV1)
Časové okno: Baseline
Individuals forced expiratory volume in 1-sec (FEV1) as assessed by spirometry
Baseline
FEV1/FVC
Časové okno: Baseline
Individuals FEV1-to-forced vital capacity (FVC) ratio
Baseline
Modified Medical Research Council Questionnaire on Breathlessness
Časové okno: Baseline
Self-reported intensity of activity related breathlessness as assessed by the modified Medical Research Council (mMRC) dyspnea scale (0-4). This questionnaire was used to measure participants' breathlessness burden using a single item scale from 0 to 4, where a score of 0-1 indicated mild breathlessness and 2-4 indicated increased breathlessness.
Baseline
COPD Assessment Test
Časové okno: Baseline
This questionnaire measure the impact COPD is having on well being and daily life. The CAT is an eight-item semantic differential scale from 0 to 5, where 0 is no impact and 5 is extremely impactful. Items include: I never cough| I cough all the time, I have no phlegm (mucus) in my chest at all | My chest is completely full of phlegm (mucus), My chest does not feel tight at all | My chest feels very tight, When I walk up a hill or one flight of stairs, I am not breathless | When I walk up a hill or one flight of stairs, I am very breathless, I am not limited doing any activities at home| I am very limited doing activities at home, I am confident leaving my home despite my lung condition| I am not at all confident leaving my home because of my lung condition, I sleep soundly | I don't sleep soundly because of my lung condition, I have lots of energy I have no energy at all. Participants' scores were totaled and a score of ≥ 10 indicated higher than normal burden of disease.
Baseline
Godin Leisure Time Physical Activity Questionnaire
Časové okno: Baseline
Self-reported physical activity levels measured in length of bouts over the previous 7 days to determine physical activity frequency.
Baseline
Satisfaction of Life Questionnaire
Časové okno: Baseline
This 5 item questionnaire was used to measure participants' level of life satisfaction. The higher the score, the higher the sense of life satisfaction. A score from 5-9 indicated extremely dissatisfied, 10-14 is dissatisfied, 15-19 indicated slightly below average life satisfaction. 20-24 is the average score, 25-29 is a high score indicative of higher life satisfaction and a score between 30-35 is a very high score and represent very high life satisfaction.
Baseline
Number of Participants With Exacerbations Due to COPD in the Preceding 12 Months
Časové okno: baseline
An exacerbation was defined as a change in medication due to a COPD exacerbation (i.e., the prescription of prednisone or a medical action plan) as indicated in the medical chart or hospital admission due to a COPD exacerbation.
baseline

Spolupracovníci a vyšetřovatelé

Zde najdete lidi a organizace zapojené do této studie.

Spolupracovníci

Vyšetřovatelé

  • Vrchní vyšetřovatel: Shane N Sweet, Ph.D., McGill University

Publikace a užitečné odkazy

Osoba odpovědná za zadávání informací o studiu tyto publikace poskytuje dobrovolně. Mohou se týkat čehokoli, co souvisí se studiem.

Termíny studijních záznamů

Tato data sledují průběh záznamů studie a předkládání souhrnných výsledků na ClinicalTrials.gov. Záznamy ze studií a hlášené výsledky jsou před zveřejněním na veřejné webové stránce přezkoumány Národní lékařskou knihovnou (NLM), aby se ujistily, že splňují specifické standardy kontroly kvality.

Hlavní termíny studia

Začátek studia

1. listopadu 2016

Primární dokončení (Aktuální)

1. října 2017

Dokončení studie (Aktuální)

12. prosince 2018

Termíny zápisu do studia

První předloženo

26. dubna 2016

První předloženo, které splnilo kritéria kontroly kvality

18. listopadu 2016

První zveřejněno (Odhad)

22. listopadu 2016

Aktualizace studijních záznamů

Poslední zveřejněná aktualizace (Aktuální)

24. prosince 2020

Odeslaná poslední aktualizace, která splnila kritéria kontroly kvality

1. prosince 2020

Naposledy ověřeno

1. prosince 2020

Více informací

Termíny související s touto studií

Další identifikační čísla studie

  • 15-203-MUHC

Plán pro data jednotlivých účastníků (IPD)

Plánujete sdílet data jednotlivých účastníků (IPD)?

NE

Informace o lécích a zařízeních, studijní dokumenty

Studuje lékový produkt regulovaný americkým FDA

Ne

Studuje produkt zařízení regulovaný americkým úřadem FDA

Ne

Tyto informace byly beze změn načteny přímo z webu clinicaltrials.gov. Máte-li jakékoli požadavky na změnu, odstranění nebo aktualizaci podrobností studie, kontaktujte prosím register@clinicaltrials.gov. Jakmile bude změna implementována na clinicaltrials.gov, bude automaticky aktualizována i na našem webu .

Klinické studie na Patient Survey

3
Předplatit